Exor's net asset value (NAV) declined by 3.9% in the first half of the year, reflecting ongoing portfolio adjustments. The company is reducing its automotive exposure while increasing stakes in companies like Philips and Lingotto. A €500 million share buyback is expected to enhance NAV per share, and Exor maintains strong financial flexibility for future investments and mergers. Portfolio simplification continues with exits from GEDI, Lifenet, and NUO, and the sale of Welltec yielded a solid 2.4x multiple on invested capital. Despite recent gains in share price, Exor still trades at a significant discount to its NAV, supporting a positive investment outlook and a Buy rating.
Exor stock is noted for a €500 million share buyback aimed at addressing its NAV discount. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Sep 25, 2026 18:13 WIB: out of 85 priced stocks, 63 rose and 15 fell today. Notable movers include WULF at USD 16.61 with a 1-day change of +1.96% and a typical hold time of 15 days, DB at USD 36.30 with a 1-day change of +1.91% and 100% buy order activity, and MARA at USD 13.16 with a 1-day change of +1.86% but 90% sell order activity.
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
AbbVie and Johnson & Johnson are both strong dividend stocks trading near their 52-week highs, but they differ significantly in risk and growth. AbbVie shows faster revenue growth and a higher dividend yield, driven by its immunology drugs, but faces...
